The Association of Urine Arsenic with Prevalent and Incident Chronic Kidney Disease: Evidence from the Strong Heart Study

Zheng, Laura Y.; Umans, Jason G.; Yeh, Fawn; Francesconi, Kevin A.; Goessler, Walter; Silbergeld, Ellen K; Bandeen-Roche, Karen; Guallar, Eliseo; Howard, Barbara V.; Weaver, Virginia M.; Navas-Acien, Ana

doi:10.1097/EDE.0000000000000313

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

The Association of Urine Arsenic with Prevalent and Incident Chronic Kidney Disease: Evidence from the Strong Heart Study

Published Date:

Jul 2015

Publisher's site:

http://dx.doi.org/10.1097/EDE.0000000000000313 New Site Icon

Source:

Epidemiology. 26(4):601-612.

[PDF - 527.16 KB]

Details:

Personal Authors:

Zheng, Laura Y. ; Umans, Jason G. ; Yeh, Fawn ; Francesconi, Kevin A. ; Goessler, Walter ; ... More ▼

Keywords:

[+]

Pubmed ID:

25929811

Pubmed Central ID:

PMC4844343

Description:

Background

Few studies have evaluated associations between low to moderate arsenic levels and chronic kidney disease (CKD). The objective was to evaluate the associations of inorganic arsenic exposure with prevalent and incident CKD in American Indian adults.

Methods

We evaluated the associations of inorganic arsenic exposure with CKD in American Indians who participated in the Strong Heart Study (SHS) in 3,851 adults aged 45–74 years in a cross-sectional analysis, and 3,119 adults with follow-up data in a prospective analysis. Inorganic arsenic, monomethylarsonate, and dimethylarsinate were measured in urine at baseline. CKD was defined as eGFR≤60 mL/min/1.73m2, kidney transplant or dialysis.

Results

CKD prevalence was 10.3%. The median (IQR) concentration of inorganic plus methylated arsenic species (total arsenic) in urine was 9.7 (5.8, 15.7) μg/L. The adjusted OR (95% CI) of prevalent CKD for an interquartile range in total arsenic was 0.7 (0.6, 0.8), mostly due to an inverse association with inorganic arsenic (OR 0.4 (0.3, 0.4)). Monomethylarsonate and dimethylarsinate were positively associated with prevalent CKD after adjustment for inorganic arsenic (OR 3.8 and 1.8). The adjusted HR of incident CKD for an IQR in ΣAs was 1.2 (1.03, 1.41). The corresponding HR for inorganic arsenic, monomethylarsonate and dimethylarsinate were 1.0 (0.9, 1.2), 1.2 (1.00, 1.3) and 1.2 (1.0, 1.4).

Conclusions

The inverse association of urine inorganic arsenic with prevalent CKD suggests that kidney disease affects excretion of inorganic arsenic. Arsenic species were positively associated with incident CKD. Studies with repeated measures are needed to further characterize the relationship between arsenic and kidney disease development.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

5T32HL007024/HL/NHLBI NIH HHS/United States
HL090863/HL/NHLBI NIH HHS/United States
HL41642/HL/NHLBI NIH HHS/United States
HL41652/HL/NHLBI NIH HHS/United States
HL41654/HL/NHLBI NIH HHS/United States
HL65521/HL/NHLBI NIH HHS/United States
P30ES03819/ES/NIEHS NIH HHS/United States
R01 ES021367/ES/NIEHS NIH HHS/United States
R01ES021367/ES/NIEHS NIH HHS/United States
T32 ES007141/ES/NIEHS NIH HHS/United States
T32 ES103650/ES/NIEHS NIH HHS/United States
T42OH008428/OH/NIOSH CDC HHS/United States
UL1 TR001079/TR/NCATS NIH HHS/United States

Supporting Files:

NIHMS764370-supplement-Supplement_1.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
NIHMS764370-supplement-Supplement_2.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
NIHMS764370-supplement-Supplement_3.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
NIHMS764370-supplement-Supplement_4.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
NIHMS764370-supplement-Supplement_5.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
nihms764370.nxml	application/octet-stream
nihms764370f1.gif	image/gif
nihms764370f1.jpg	image/jpeg
nihms764370f2.gif	image/gif
nihms764370f2.jpg	image/jpeg
nihms764370f3.gif	image/gif
nihms764370f3.jpg	image/jpeg

No Related Documents.

You May Also Like:

Relationship between heart rate variability and pulse wave velocity and their association with patient outcomes in chronic kidney disease

Personal Author:

Chandra, Preeti; Sands, Robin L.; Gillespie, Brenda W.; Levin, Nathan W.; Kotanko, Peter; Kiser, Margaret; Finkelstein, Fredric; Hinderliter, Alan; Rajagopalan, Sanjay; Sengstock, David; Saran, Rajiv;

Published:

Jan 2014

Source:

Clin Nephrol. 2014 ; 81(1):9-19.

Description:

Arterial stiffness and low heart rate variability (HRV) have each been associated with increased cardiovascular risk in a variety of patient populations. We explored the relationship between HRV and pulse wave velocity (PWV measure of arterial stiffn...

File Type:

[PDF - 471.64 KB]
Utility of Anthropometric Measures in a Multiethnic Population: Their Association with Prevalent Diabetes, Hypertension and Other Chronic Disease Comorbidities

Personal Author:

Tarleton, Heather P.; Smith, Lisa. V.; Zhang, Zuo-Feng; Kuo, Tony;

Published:

Jun 2014

Source:

J Community Health. 39(3):471-479.

Description:

Body mass index (BMI) and waist circumference (WC) are two common anthropometric measures of obesity in clinical and public health practice. Consensus, however, remains elusive regarding their utility for predicting cardiovascular disease risk in mul...

File Type:

[PDF - 579.63 KB]
URINE ARSENIC CONCENTRATION AND OBSTRUCTIVE PULMONARY DISEASE IN THE U.S. POPULATION

Personal Author:

Amster, Eric D.; Cho, Jang Ik; Christiani, David;

Published:

2011

Source:

J Toxicol Environ Health A. 74(11):716-727.

Description:

Arsenic (As) is a known carcinogen commonly found in drinking water. An emerging body of evidence suggests that exposure to inorganic As may be associated with nonmalignant respiratory disease. The aim of this study was to determine whether there is ...

File Type:

[PDF - 481.96 KB]
Arsenic and Chronic Kidney Disease: A Systematic Review

Personal Author:

Zheng, Laura; Kuo, Chin-Chi; Fadrowski, Jeffrey; Agnew, Jackie; Weaver, Virginia M.; Navas-Acien, Ana;

Published:

Sep 1 2014

Source:

Curr Environ Health Rep. 1(3):192-207.

Description:

In epidemiologic studies, high arsenic exposure has been associated with adverse kidney disease outcomes. We performed a systematic review of the epidemiologic evidence of the association between arsenic and various kidney disease outcomes. The searc...

File Type:

[PDF - 802.47 KB]
Guidelines for vaccinating dialysis patients and patients with chronic kidney disease; summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP)

Personal Author:

Chi, Carolyn; Moore, Matt; Murphy, Trudy V.; Patel, Priti R.; Pilishvili, Tamara; Strikas, Raymond A.;

Corporate Author:

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.);

Published:

December 2012

Description:

This summary is not meant to apply to chronic kidney disease patients who are recently post-transplant. These patients are considered more significantly immunosuppressed than those who have only chronic kidney disease, with or without dialysis. Deter...

Status:

current

File Type:

[PDF - 833.32 KB]